Vorapaxar: The Current Role and Future Directions of a Novel Protease-Activated Receptor Antagonist for Risk Reduction in Atherosclerotic Disease. Gryka RJ, Buckley LF, Anderson SM. Drugs R D. 2017 Mar;17(1):65-72. doi: 10.1007/s40268-016-0158-4. PMID: 28063023. Review.

Activity: Other activity typesOther

Period2017